BAYN.DE Bayer AG Loading...

Loading chart...
Top Calls
Feed
Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
Loading...
0 selected
All Content✓
Source feeds
Buzzberg's Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
10:20
Jun 19
Charlie Wells Bloomberg Reporter Bloomberg Markets
German pharma faces US tariff risk.
The US is opening a Section 301 trade investigation into Germany over healthcare cost‑cutting legislation. This could lead to tariffs that hit German pharmaceutical stocks, especially Bayer, which derives about one‑third of its revenue from the US.
BAYN.DE
MED

About BAYN.DE Analyst Coverage

Buzzberg tracks BAYN.DE (Bayer AG) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade ideas tracked. Past 7 days: 1 watch. Latest voices: Charlie Wells.